Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-03-25

Clinical Trial Update: Randomized Study of Botulinum Toxin Type A for Achalasia [NA]

View source ↗

Summary

This document reports the completion of a randomized study evaluating Botulinum toxin type A for esophageal achalasia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botulinum toxin type A (OnabotulinumtoxinA) (onabotulinumtoxinA)

Snippet

Sponsor: University of Texas | Conditions: Esophageal Achalasia | NA | Status: COMPLETED